These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9001420)
1. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576 [TBL] [Abstract][Full Text] [Related]
3. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
4. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104 [TBL] [Abstract][Full Text] [Related]
5. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381 [TBL] [Abstract][Full Text] [Related]
6. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183 [TBL] [Abstract][Full Text] [Related]
7. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. Parry D; Bates S; Mann DJ; Peters G EMBO J; 1995 Feb; 14(3):503-11. PubMed ID: 7859739 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558 [TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541 [TBL] [Abstract][Full Text] [Related]
10. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927 [TBL] [Abstract][Full Text] [Related]
11. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia. Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528 [TBL] [Abstract][Full Text] [Related]
12. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328 [TBL] [Abstract][Full Text] [Related]
13. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes. Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087 [TBL] [Abstract][Full Text] [Related]
16. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Grønbaek K; Nedergaard T; Andersen MK; thor Straten P; Guldberg P; Møller P; Zeuthen J; Ebbe Hansen N; Hou-Jensen K; Ralfkiaer E Leukemia; 1998 Aug; 12(8):1266-71. PubMed ID: 9697882 [TBL] [Abstract][Full Text] [Related]
17. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Nielsen NH; Emdin SO; Cajander J; Landberg G Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115 [TBL] [Abstract][Full Text] [Related]
18. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610 [TBL] [Abstract][Full Text] [Related]
19. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]